These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1517556)

  • 21. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC; Goodman WK; Price LH; McDougle CJ; Charney DS
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 24. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT; Insel TR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obsessive-compulsive disorder.
    George MS
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ; Stagno SJ; Calabrese JR
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L; Solyom C; Ledwidge B
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluvoxamine in the treatment of obsessive compulsive disorder.
    Montgomery SA; Manceaux A
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():5-9. PubMed ID: 1355499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychol Med; 2004 Oct; 34(7):1367-8; author reply 1368-9. PubMed ID: 15697063
    [No Abstract]   [Full Text] [Related]  

  • 39. Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly.
    Austin LS; Zealberg JJ; Lydiard RB
    J Nerv Ment Dis; 1991 Oct; 179(10):634-5. PubMed ID: 1919549
    [No Abstract]   [Full Text] [Related]  

  • 40. Serotonin: la chica de moda in biological psychiatry?
    Banki CM
    Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.